Oncotarget

Vol 9, No 52

July 6, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 52 of Oncotarget features Figure 5, "Low KIBRA expression predicts poor breast cancer patient outcome," by Mussell, et al.

Table of Contents

Editorial

CD19 directed CAR T cell therapy in diffuse large B-cell lymphoma

CD19 directed CAR T cell therapy in diffuse large B-cell lymphoma

https://doi.org/10.18632/oncotarget.25688

Alfonso Quintás-Cardama
29843-29844
PDF  |  Order a Reprint

Research Papers: Pathology

Anchorage-dependent multicellular aggregate formation induces a quiescent stem-like intractable phenotype in pancreatic cancer cells

Anchorage-dependent multicellular aggregate formation induces a quiescent stem-like intractable phenotype in pancreatic cancer cells

https://doi.org/10.18632/oncotarget.25732

Yukiko Miyatake, Yusuke Ohta, Shunji Ikeshita,  and Masanori Kasahara
29845-29856
Abstract  |  PDF  |  HTML  |  Order a Reprint

Research Papers

Screening of microRNAs for a repressor of hepatitis B virus replication

Screening of microRNAs for a repressor of hepatitis B virus replication

https://doi.org/10.18632/oncotarget.25557

Yutaka Naito, Susumu Hamada-Tsutsumi, Yusuke Yamamoto, Akiko Kogure, Yusuke Yoshioka, Koichi Watashi, Takahiro Ochiya,  and Yasuhito Tanaka
29857-29868
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Effect of TP53 contact and conformational mutations on cell survival and erythropoiesis of human hematopoietic stem cells in a long term culture model

Effect of TP53 contact and conformational mutations on cell survival and erythropoiesis of human hematopoietic stem cells in a long term culture model

https://doi.org/10.18632/oncotarget.25581

Azam Salari, Kathrin Thomay, Jana Lentes, Juliane Ebersold, Maike Hagedorn, Britta Skawran, Claudia Davenport, Axel Schambach, Brigitte Schlegelberger,  and Gudrun Göhring
29869-29876
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Heuristic value-based framework for lung cancer decision-making

Heuristic value-based framework for lung cancer decision-making

https://doi.org/10.18632/oncotarget.25643

Isa Mambetsariev, Rebecca Pharaon, Arin Nam, Kevin Knopf, Benjamin Djulbegovic, Victoria M. Villaflor, Everett E. Vokes,  and Ravi Salgia
29877-29891
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The regulatory interplay between Oct-1 isoforms contributes to hematopoiesis and the isoforms imbalance correlates with a malignant transformation of B cells

The regulatory interplay between Oct-1 isoforms contributes to hematopoiesis and the isoforms imbalance correlates with a malignant transformation of B cells

https://doi.org/10.18632/oncotarget.25648

Elizaveta V. Pankratova, Alexander G. Stepchenko, Irina D. Krylova, Tatiana N. Portseva,  and Sofia G. Georgieva
29892-29905
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling

A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling

https://doi.org/10.18632/oncotarget.25692

Federico Bocci, Mohit Kumar Jolly, Jason Thomas George, Herbert Levine,  and José Nelson Onuchic
29906-29920
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinoma

Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinoma

https://doi.org/10.18632/oncotarget.25699

Georgi Atanasov, Corinna Dietel, Linda Feldbrügge, Christian Benzing, Felix Krenzien, Andreas Brandl, Shadi Katou, Katrin Schierle, Simon C. Robson, Katrin Splith, Georg Wiltberger, Anja Reutzel-Selke, Sven Jonas, Andreas Pascher, Marcus Bahra, Johann Pratschke,  and Moritz Schmelzle
29921-29933
Abstract  |  PDF  |  HTML  |  Order a Reprint

The inhibition of malignant melanoma cell invasion of bone by the TLR7 agonist R848 is dependent upon pro-inflammatory cytokines produced by bone marrow macrophages

The inhibition of malignant melanoma cell invasion of bone by the TLR7 agonist R848 is dependent upon pro-inflammatory cytokines produced by bone marrow macrophages

https://doi.org/10.18632/oncotarget.25711

Yoko Manome, Dai Suzuki, Ayako Mochizuki, Emi Saito, Kiyohito Sasa, Kentaro Yoshimura, Tomio Inoue, Masamichi Takami, Katsunori Inagaki, Takahiro Funatsu,  and Ryutaro Kamijo
29934-29943
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study

Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study

https://doi.org/10.18632/oncotarget.25714

Theo Pirich, Elisabeth Zwickl-Traxler, Martin Pecherstorfer,  and Josef Singer
29944-29956
Abstract  |  PDF  |  HTML  |  Order a Reprint

Aquaporin 1 suppresses apoptosis and affects prognosis in esophageal squamous cell carcinoma

Aquaporin 1 suppresses apoptosis and affects prognosis in esophageal squamous cell carcinoma

https://doi.org/10.18632/oncotarget.25722

Yuzo Yamazato, Atsushi Shiozaki, Daisuke Ichikawa, Toshiyuki Kosuga, Katsutoshi Shoda, Tomohiro Arita, Hirotaka Konishi, Shuhei Komatsu, Takeshi Kubota, Hitoshi Fujiwara, Kazuma Okamoto, Mitsuo Kishimoto, Eiichi Konishi, Yoshinori Marunaka,  and Eigo Otsuji
29957-29974
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Loss of KIBRA function activates EGFR signaling by inducing AREG

Loss of KIBRA function activates EGFR signaling by inducing AREG

https://doi.org/10.18632/oncotarget.25724

Ashley L. Mussell, Kayla E. Denson, He Shen, Yanmin Chen, Nuo Yang, Costa Frangou,  and Jianmin Zhang
29975-29984
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Clinical Research Papers

Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapy

Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapy

https://doi.org/10.18632/oncotarget.25695

Claudius Melzig, Azadeh Fahim Golestaneh, Walter Mier, Christian Schwager, Samayita Das, Julian Schlegel, Felix Lasitschka, Hans-Ulrich Kauczor, Jürgen Debus, Uwe Haberkorn,  and Amir Abdollahi
29985-30004
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Reviews

Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA

Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA

https://doi.org/10.18632/oncotarget.25487

Jacob E. Robinson,  and Christine E. Cutucache
30005-30022
Abstract  |  PDF  |  HTML  |  Order a Reprint

Corrections

Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11

Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11

https://doi.org/10.18632/oncotarget.25775

Hironaga Satake, Yu Sunakawa, Yuji Miyamoto, Masato Nakamura, Hiroshi Nakayama, Manabu Shiozawa, Akitaka Makiyama, Kazuma Kobayashi, Yutaro Kubota, Misuzu Mori, Masahito Kotaka, Akinori Takagane, Masahiro Gotoh, Masahiro Takeuchi, Masashi Fujii, Wataru Ichikawa,  and Takashi Sekikawa
30023-30023
Correction  |  PDF

Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma

Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma

https://doi.org/10.18632/oncotarget.25776

Saurabh Agarwal, Giorgio Milazzo, Kimal Rajapakshe, Ronald Bernardi, Zaowen Chen, Barbieri Eveline, Jan Koster, Giovanni Perini, Cristian Coarfa,  and Jason M. Shohet
30024-30024
Correction  |  PDF


Copyright © 2018 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC